Article
Docosahexaenoic acid significantly reduces tumor cell growth in preclinical models of…
medRxiv · 2020 · Bilyk, O.; Hamedi, B.; Dutta, I.; Newell, M.; Bukhari, A. B.; Gamper, A. M.; McVea, R. C.; Liu, J.; Schueler, J.; Siegers, G. M.; Field, C. J.; Postovit, L.-M.
Key facts
| Title | Docosahexaenoic acid significantly reduces tumor cell growth in preclinical models of ovarian cancer |
|---|---|
| First author | Bilyk, O.; Hamedi, B.; Dutta, I.; Newell, M.; Bukhari, A. B.; Gamper, A. M.; McVea, R. C.; Liu, J.; Schueler, J.; Siegers, G. M.; Field, C. J.; Postovit, L.-M. |
| Journal | medRxiv |
| Published | Nov 10, 2020 |
| DOI | 10.1101/2020.11.10.376152 |
| Devices mentioned | K042884 |
| Product codes mentioned | KPA, MYA, MXZ, NJT, NKF |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1